Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. colonoscopy
Show results for
Products
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Colonoscopy Articles & Analysis

18 news found

Iterative Scopes Partners with One GI to Advance Gastrointestinal Care Through Artificial Intelligence

Iterative Scopes Partners with One GI to Advance Gastrointestinal Care Through Artificial Intelligence

The technology uses computational algorithms integrated with existing colonoscopy imagery and videos to determine clinical trial eligibility, speeding up the clinical trial timelines and allowing more patients to access potentially life-changing treatments. ...

ByIterative Health, Inc.


Iterative Health Redefines Approach to Precision GI Care

Iterative Health Redefines Approach to Precision GI Care

SKOUT significantly improves overall adenoma detection compared to standard colonoscopy. In its registration trial, published in Gastroenterology, SKOUT demonstrated a 27% relative increase in the detection of adenomas per colonoscopy.1 Lastly, AI Documentation, which is currently in development, may soon have the power to provide detailed and accurate procedure ...

ByIterative Health, Inc.


Iterative Scopes Receives FDA Clearance for AI-Assisted Polyp Detection Device SKOUT

Iterative Scopes Receives FDA Clearance for AI-Assisted Polyp Detection Device SKOUT

Colorectal cancer is the second leading cause of cancer-related deaths in the United States and Europe,2 3 due in part to the high volumes of adenomas – approximately 26%4 – that endoscopists miss when conducting a colonoscopy. In its registration trial, SKOUT was found to improve adenoma detection, as measured by adenomas per colonoscopy (APC). ...

ByIterative Health, Inc.


Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq`s Minimum Bid Price Requirement

Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq`s Minimum Bid Price Requirement

C-Scan is not intended to replace colonoscopy. A positive C-Scan result should be followed by colonoscopy. ...

ByCheck-Cap Ltd.


Check-Cap Announces Initiation of the U.S. Pivotal Trial

Check-Cap Announces Initiation of the U.S. Pivotal Trial

However, the acceptance of the colonoscopy procedure is low, in part due to the invasiveness of the procedure and bowel cleansing. We believe Check-Cap has the potential to reach those who are deterred by colonoscopy and to help improve colon cancer screening through a patient-friendly solution without the need of bowel cleaning, sedation, and fasting." ...

ByCheck-Cap Ltd.


Guardant Health Announces Shieldâ„¢ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults

Guardant Health Announces Shieldâ„¢ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults

Barriers associated with currently available methods, such as a colonoscopy or a stool-based test, can make the process unpleasant, time-consuming and difficult to complete.2 With a simple blood draw, the Shield test overcomes these barriers because it requires no special preparation, no sedation, no dietary changes, no extra time away from family or work, and it can be completed ...

ByGuardant Health, Inc.


Immundiagnostik`s Colorectal Cancer Screening Portfolio

Immundiagnostik`s Colorectal Cancer Screening Portfolio

An advantage of quantitative tests is the ability to vary cut-off values, which allows an adaption to current conditions, such as national colonoscopy resources, gender and age-specific differences. In addition, this makes it possible to react quickly to new findings regarding the cut-off (e.g. adjustment during an ongoing screening procedure) (Zorzi et al., 2015., Segnan N et ...

ByImmundiagnostik AG


Life-Changing Watchman Procedure for Patient with Kidney Disease

Life-Changing Watchman Procedure for Patient with Kidney Disease

A life-threating emergency One day Sheldon’s fears became reality after he suffered a massive intestinal bleed following a colonoscopy. “His medical team struggled to get his bleeding under control, and because they were concerned he could bleed to death during the two-hour ambulance ride, they airlifted him to CentraCare – St. ...

ByEchoPixel, Inc.


Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan

Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan

The second part will include a statistically powered, randomized study which will compare the performance of C-Scan to traditional colonoscopy. About Check-Cap Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC)screening through the introduction of C-Scan®, thefirst and onlypatient-friendly preparation-freescreening test to ...

ByCheck-Cap Ltd.


Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan

Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan

Yet, a known barrier for some patients is the required bowel cleansing for colonoscopy and invasiveness of the procedure. Less invasive alternatives are needed to engagea percentage of the population that avoids regular screening," said Seth A. ...

ByCheck-Cap Ltd.


Check-Cap Announces Grant of Patent Covering C-Scan`s Proprietary Tracking Technology in the U.S. and Additional Major Market Territories

Check-Cap Announces Grant of Patent Covering C-Scan`s Proprietary Tracking Technology in the U.S. and Additional Major Market Territories

C-Scan is not intended to replace colonoscopy. A positive C-Scan result should be followed by ...

ByCheck-Cap Ltd.


Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation

Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation

C-Scan is not intended to replace colonoscopy. A positive C-Scan result should be followed by ...

ByCheck-Cap Ltd.


EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record

EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record

DiLumen has been proven effective in lower GI procedures and complements EMR and ESD procedures for removal of complex polyps, as well as with patients who have undergone difficult or incomplete screening colonoscopies due to a challenging or tortuous colon. ...

ByLumendi Ltd.


Proximie and Vodafone in successful 5G remotely assisted surgery trials

Proximie and Vodafone in successful 5G remotely assisted surgery trials

Trial will be used in the diagnosis and treatment of colon cancer, and in colonoscopy training. Trial at Cardiff and Vale University Health Board has been funded by UK Innovation & Research. ...

ByProximie Limited


Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan

C-Scan is intended for candidateswho are at average-risk for CRC and who are poor candidates for colonoscopy or decline colonoscopy, or who had an incomplete optical colonoscopy.The pivotal study will evaluate safety and performance of C-Scan as well as subject compliance with C-Scan. ...

ByCheck-Cap Ltd.


Check-Cap Announces Positive Results from U.S. Pilot Study of C-Scan System

Check-Cap Announces Positive Results from U.S. Pilot Study of C-Scan System

Each patient ingested a C-Scan capsule and also underwent a fecal immunochemical test (FIT) as well as a comparative colonoscopy, which was performed by an independent gastroenterologist who was blinded to the corresponding test results. ...

ByCheck-Cap Ltd.


Edinburgh Molecular Imaging Appoints Bernhard Sixt as new Chief Executive Officer

Edinburgh Molecular Imaging Appoints Bernhard Sixt as new Chief Executive Officer

It has been safely administered to 69 patients so far demonstrating encouraging data and in a phase 1/2a colonoscopy study demonstrated a 17% increase in cancer lesion detection compared to standard colonoscopy, and increased detection of high risk lesions. ...

ByEdinburgh Molecular Imaging


EM Imaging obtains global licence for optical agent that detects cancer early

EM Imaging obtains global licence for optical agent that detects cancer early

In a recent scientific study, reported in the prestigious scientific journal Nature Medicine, the EMI-137 agent allowed doctors to see more early-stage colorectal cancer (CRC) and precancerous tumours, which can then easily be removed via colonoscopy. However, screening with a colonoscope, which is currently the most common method, can miss up to 25% of precancerous growths, ...

ByEdinburgh Molecular Imaging

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT